⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
NVS News
Novartis AG
ALK Inhibitors Market Set for Transformational Growth at a CAGR of 4% During the Forecast Period (2026-2036) Backed by Next-Generation Targeted Therapies| DelveInsight
prnewswire.com
PFE
MRK
LLY
AMGN
BMY
NVS
GILD
AZN
REGN
SNY
TEVA
IMUX
Novartis verzeichnete im zweiten Quartal Umsatzsteigerungen und baute die Pipeline weiter aus; Prognose für das Geschäftsjahr bekräftigt
globenewswire.com
NVS
Novartis delivered sales growth in Q2 and further advanced the pipeline; Full-year guidance reaffirmed
globenewswire.com
NVS
PharmaBlock bringt weltweit führende Branchenvertreter in Zürich zusammen, um die Grüne Chemie für eine nachhaltige pharmazeutische Produktion voranzutreiben
prnewswire.com
NVS
PFE
AZN
The American Kidney Fund and IgA Nephropathy Foundation Create New IgA Nephropathy Patient Guidelines (UPDATE)
globenewswire.com
NVS
VRTX
CDTX
Malignant Pleural Effusion Market to Register Incremental Growth at a CAGR of 4.9% During the Forecast Period (2026–2036) | DelveInsight
globenewswire.com
CRSP
MRK
NVS
BMY
AZN
PFE
REGN
PharmaBlock réunit à Zurich les leaders mondiaux du secteur afin de faire progresser la chimie verte au service d'une production pharmaceutique durable
prnewswire.com
NVS
PFE
BMY
SNY
AZN
PharmaBlock impulsa la química verde en la fabricación farmacéutica sostenible
prnewswire.com
NVS
PFE
AZN
The American Kidney Fund and IgA Nephropathy Foundation Create New IgA Nephropathy Patient Guidelines
globenewswire.com
NVS
VRTX
CDTX
Smart Inhalers Market to Reach $12.1 Billion by 2030, Driven by Poor Medication Adherence Crisis
globenewswire.com
AZN
GSK
NVS